The latest closing stock price for Adaptive Biotechnologies as of November 20, 2024 is 4.42.
An investor who bought $1,000 worth of Adaptive Biotechnologies stock at the IPO in 2019 would have $-890 today, roughly -1 times their original investment - a -35.73% compound annual growth rate over 5 years.
The all-time high Adaptive Biotechnologies stock closing price was 67.74 on January 22, 2021.
The Adaptive Biotechnologies 52-week high stock price is 6.70, which is 51.6% above the current share price.
The Adaptive Biotechnologies 52-week low stock price is 2.28, which is 48.4% below the current share price.
The average Adaptive Biotechnologies stock price for the last 52 weeks is 4.09.
An investor who bought $1,000 worth of Adaptive Biotechnologies stock at the IPO in 2019 would have $-890 today, roughly -1 times their original investment - a -35.73% compound annual growth rate over 5 years.
The all-time high Adaptive Biotechnologies stock closing price was 67.74 on January 22, 2021.
The Adaptive Biotechnologies 52-week high stock price is 6.70, which is 51.6% above the current share price.
The Adaptive Biotechnologies 52-week low stock price is 2.28, which is 48.4% below the current share price.
The average Adaptive Biotechnologies stock price for the last 52 weeks is 4.09.